(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 13.33% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.76%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.32%.
Staar Surgical Co's revenue in 2026 is $239,442,000.On average, 14 Wall Street analysts forecast STAA's revenue for 2026 to be $15,061,283,118, with the lowest STAA revenue forecast at $12,470,280,963, and the highest STAA revenue forecast at $17,910,246,696. On average, 14 Wall Street analysts forecast STAA's revenue for 2027 to be $16,155,514,871, with the lowest STAA revenue forecast at $13,664,033,342, and the highest STAA revenue forecast at $18,138,995,596.
In 2028, STAA is forecast to generate $17,258,163,791 in revenue, with the lowest revenue forecast at $15,320,729,923 and the highest revenue forecast at $19,802,623,963.